McKesson Corporation appears to be in a strong competitive position, largely outperforming its competitors on various trading days. The company has seen notable insider trading, with the sale of over $225k in company stock and shares worth over $7m sold by executives Smith LeAnn B and Thomas L Rodgers. Yet, the institutional ownership of MCK stands firm at 88%. Revenue growth remains robust, leading to increased full-year guidance despite a slight earnings dip. MCK's stock has hit a 52-week high multiple times, backed by strong momentum and reportedly undervalued status. The company's intrinsic value is potentially 82% above its share price, suggesting further growth potential. However, there have been instances where MCK has underperformed compared to competitors, and concerns around its appropriateness for dividend investments are present. Recently the company has announced its intention to sell the Canadian Rexall Pharmacy Group. Additionally, repeated insiders' sales have raised certain caution flags.
Mckesson Corporation MCK News Analytics from Mon, 18 Sep 2023 07:00:00 GMT to Fri, 31 May 2024 20:46:00 GMT -
Rating 6
- Innovation 2
- Information 5
- Rumor -6
